 |
PDBsum entry 4mds
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
4mds
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Discovery of n-(benzo[1,2,3]triazol-1-yl)-n-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (sars- cov) 3clpro inhibitors: identification of ml300 and non-covalent nanomolar inhibitors with an induced-fit binding
|
|
Structure:
|
 |
3c-like proteinase. Chain: a. Fragment: unp residues 3241-3542. Synonym: 3cl protease, 3cl-pro, 3clp, nsp5. Engineered: yes
|
|
Source:
|
 |
Sars coronavirus. Sars-cov. Organism_taxid: 227859. Gene: 1a. Expressed in: escherichia coli. Expression_system_taxid: 562
|
|
Resolution:
|
 |
|
1.60Å
|
R-factor:
|
0.172
|
R-free:
|
0.212
|
|
|
Authors:
|
 |
A.D.Mesecar,V.Grum-Tokars
|
|
Key ref:
|
 |
M.Turlington
et al.
(2013).
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.
Bioorg Med Chem Lett,
23,
6172-6177.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
23-Aug-13
|
Release date:
|
02-Oct-13
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0C6U8
(R1A_CVHSA) -
Replicase polyprotein 1a from Severe acute respiratory syndrome coronavirus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
4382 a.a.
303 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class 1:
|
 |
E.C.2.7.7.50
- mRNA guanylyltransferase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
a 5'-end diphospho-ribonucleoside in mRNA + GTP + H+ = a 5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA + diphosphate
|
 |
 |
 |
 |
 |
5'-end diphospho-ribonucleoside in mRNA
|
+
|
GTP
|
+
|
H(+)
|
=
|
5'-end (5'-triphosphoguanosine)-ribonucleoside in mRNA
|
+
|
diphosphate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
Enzyme class 2:
|
 |
E.C.3.4.19.12
- ubiquitinyl hydrolase 1.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Thiol-dependent hydrolysis of ester, thiolester, amide, peptide and isopeptide bonds formed by the C-terminal Gly of ubiquitin (a 76-residue protein attached to proteins as an intracellular targeting signal).
|
 |
 |
 |
 |
 |
Enzyme class 3:
|
 |
E.C.3.4.22.-
- ?????
|
|
 |
 |
 |
 |
 |
Enzyme class 4:
|
 |
E.C.3.4.22.69
- Sars coronavirus main proteinase.
|
|
 |
 |
 |
 |
 |
 |
 |
|
Note, where more than one E.C. class is given (as above), each may
correspond to a different protein domain or, in the case of polyprotein
precursors, to a different mature protein.
|
|
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
Bioorg Med Chem Lett
23:6172-6177
(2013)
|
|
PubMed id:
|
|
|
|
|
| |
|
Discovery of N-(benzo[1,2,3]triazol-1-yl)-N-(benzyl)acetamido)phenyl) carboxamides as severe acute respiratory syndrome coronavirus (SARS-CoV) 3CLpro inhibitors: identification of ML300 and noncovalent nanomolar inhibitors with an induced-fit binding.
|
|
M.Turlington,
A.Chun,
S.Tomar,
A.Eggler,
V.Grum-Tokars,
J.Jacobs,
J.S.Daniels,
E.Dawson,
A.Saldanha,
P.Chase,
Y.M.Baez-Santos,
C.W.Lindsley,
P.Hodder,
A.D.Mesecar,
S.R.Stauffer.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Herein we report the discovery and SAR of a novel series of SARS-CoV 3CLpro
inhibitors identified through the NIH Molecular Libraries Probe Production
Centers Network (MLPCN). In addition to ML188, ML300 represents the second probe
declared for 3CLpro from this collaborative effort. The X-ray structure of
SARS-CoV 3CLpro bound with a ML300 analog highlights a unique induced-fit
reorganization of the S2-S4 binding pockets leading to the first sub-micromolar
noncovalent 3CLpro inhibitors retaining a single amide bond.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |